Lehrstuhl für Klinische und Molekulare Virologie

Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H (2022) Schütz M, Müller R, Socher E, Wangen C, Full F, Wyler E, Wong DD, et al. Journal article Recombinant Human Cytomegalovirus Expressing an Analog-Sensitive Kinase pUL97 as Novel Tool for Functional Analyses (2022) Krämer N, Schütz M, Mato UG, Herhaus L, Marschall M, Zimmermann C Journal article Impaired cytokine production of circulating immune cells in severe asthma in response to Influenza virus (2022) Jameel KJ, Yanik S, Kamaci C, Weidinger D, Buelthoff E, Rohde S, Yusuf F, et al. Conference contribution Differential induction of lung-resident memory T cells through infection or viral vector immunization (2022) Schmidt A, Fuchs J, Lapuente D, Huebner J, Vieira Antao AI, Irrgang P, Paudyal B, et al. Conference contribution Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization (2022) Lapuente D, Fuchs J, Willar J, Antao A, Eberlein V, Uhlig N, Issmail L, et al. Conference contribution Functionality of antigen-specific T cell receptor repertoires after SARS-CoV-2 vaccination (2022) Kocher K, Drost F, Schuelein C, Moosmann C, D'Ippolito E, Busch DH, Bogdan C, et al. Conference contribution Novel, orally available immune modulator MP1032 with pan-variant anti-SARS-CoV-2 and anti-inflammatory activity (2022) Schumann S, Setz C, Schulz P, Kaiser A, Schubert U, Brysch W Conference contribution Mucosal vaccination with a viral vector vaccine induces robust lung-resident T cell responses and protects against 4T1 metastasis (2022) Oltmanns F, Vieira Antao AI, Irrgang P, Meyn V, Jörg L, Tenbusch M, Lapuente D Conference contribution Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD (2022) Peter AS, Grüner E, Socher E, Fraedrich K, Richel E, Müller-Schmucker S, Cordsmeier A, et al. Journal article Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity (2022) Maier C, Fuchs J, Irrgang P, Wissing MH, Beyerlein J, Tenbusch M, Lapuente D Journal article